SEC Form 4 · accession 0001144204-15-037115
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jyrki Mattila
Officer — Chief Business Officer
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 12:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.32 | Jun 11, 2015 | A | 10,000 | A | — | Jun 10, 2025 | Common Stock | 10,000 | 90,000 | D |
Explanation of responses
- F1Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary date of June 11, 2016, with the remaining 2/3 of the shares vesting monthly on a pro-rata basis over the following two years.